Cited by 202Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsNeuropeptides and Animal Physiology

Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators.

Bradshaw, Heather B., Rimmerman, Neta, Krey, Jocelyn F., Walker, J. Michael·2006·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Abstract

One important function of endocannabinoids and related lipid mediators in mammalian central nervous system is modulation of pain. Evidence obtained during the last decade shows that altered levels of these compounds in the brain accompany decreases in pain sensitivity. Such changes, if sexually dimorphic, could account for sex differences in pain and differences that occur during different phases of the hormonal cycle in females. To examine this possibility, we measured the levels of the pain-modulatory lipids anandamide, 2-arachidonoyl glycerol, N-arachidonoyl glycine, N-arachidonoyl gamma amino butyric acid, and N-arachidonoyl dopamine in seven different brain areas (pituitary, hypothalamus, thalamus, striatum, midbrain, hippocampus, and cerebellum) in male rats, and in female rats at five different points in the estrous cycle. The cerebellum did not demonstrate a change in endocannabinoid production across the estrous cycle, whereas all other areas tested showed significant differences in at least one of the compounds measured. These changes in levels occurred predominantly within the 36-h time period surrounding ovulation and behavioral estrus. Differences between males and females were measured as either estrous cycle-independent (all estrous cycles combined) or cycle-dependent (comparisons of males to each estrous cycle). In cycle-independent analyses, small sex differences were observed in the pituitary, hypothalamus, cerebellum, and striatum, whereas no differences were observed in the thalamus, midbrain, and hippocampus. In cycle-dependent analyses, the hypothalamus and pituitary showed largest sex differences followed by the striatum, midbrain, and hippocampus, whereas no sex differences were measured in thalamus and cerebellum. These data provide a basis for investigations into how differences in sex and hormonal status play a role in mechanisms regulating endocannabinoid production and pain.

Integrity signals

Registry

Crossref · 10.1152/ajpregu.00933.2005

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ovarian cyclical changes in cannabinoid receptor density or endocannabinoid content occur in brain areas potentially associated with nociception.

    “both studies observed ovarian cyclical changes in cannabinoid receptor density or endocannabinoid content in brain areas potentially associated with nociception, [8,44].”

    From Endocannabinoid involvement in endometriosis. (2010) · cites this paper as [8]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bradshaw, H. B., Rimmerman, N., Krey, J. F., & Walker, J. M.
Affiliations
Indiana University Bloomington (US)
Venue
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Published
2006-08
Volume
291
Issue
2
Pages
R349-R358
ISSN
  • 0363-6119 (ISSN-L)
  • 1522-1490
OpenAlex
W2041728393
Cited by
202
References
48
Citations by year
2026: 2 · 2025: 10 · 2024: 5 · 2023: 16 · 2022: 6 · 2021: 20 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 14 · 2016: 9 · 2015: 11 · 2014: 14 · 2013: 12 · 2012: 11
FWCI
6.02
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1f32da016825-01)
  • National Institute on Drug Abuse (F32-DA-016825)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
endocannabinoids, pain modulation, sex differences, estrous cycle, anandamide, 2-arachidonoylglycerol, N-arachidonoyl dopamine, hypothalamus, pituitary gland, striatum, hippocampus, midbrain, thalamus, cerebellum, ovulation
MeSH terms
Animals, Brain, Cannabinoids, Cerebellum, Chromatography, Liquid, Corpus Striatum, Female, Hippocampus, Hormones, Hypothalamus, Male, Mesencephalon, Pain, Pain Measurement, Pituitary Gland, Sex Characteristics, Mass Spectrometry, Thalamus, Rats, Sprague-Dawley, Estrous Cycle, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review